BioWorld

June 6, 2003

Millennium Trimming Operations, Staff As Focus Turns To Profits

In announcing a plan to restructure its organization, Millennium Pharmaceuticals Inc. said its goal is to focus on the commercially attractive items in its pipeline and to reach profitability by 2006. (BioWorld Today) Read More

NPS, Enzon End Merger Plans After Failing To Come To Terms

Rare, Unplumbable Contortions Of Dual Sézary Syndrome Malignancy Launch Therapeutic Clinical Trials

Discovery Labs' Surfaxin Support Trial Provides Positive Early Data

Isis, Lilly Rework Agreement For Affinitak Manufacturing

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...